Phase 1 evaluation of the safety, tolerability, and plasma and CSF pharmacokinetics of AST-004 after IV infusion in healthy volunteers
Peter Dogterom, PhD presents the Phase 1 evaluation of the safety, tolerability and plasma and CSF pharmacokinetics of AST-004 after IV infusion in healthy volunteers.